New Study Links Vaping Switch to Higher Risk of Blindness

A new study from Korea reveals a direct link between vaping and an increased risk of vision impairment and blindness. The research indicates that individuals who transition from traditional cigarettes to high-nicotine vapes face a higher probability of developing severe eye diseases compared to those who quit nicotine entirely. This finding challenges the popular belief that switching to vaping is a safer alternative to smoking.

The investigation, which analyzed nearly five years of data from the Korean National Health Insurance Service, tracked more than 32,000 adults who had previously smoked combustible cigarettes. Researchers utilized statistical methods to balance groups based on age, income, physical activity, and pre-existing health conditions, ensuring a fair comparison between complete nicotine quitters and those who switched to vaping. Participants averaged 45 years of age and were monitored for an average of 4.6 years.

During this period, the study documented 6,328 major eye disease events. Complete nicotine quitters recorded the lowest rate, with 41 cases per 1,000 person-years, while vapers saw that figure rise to 44. The study did not calculate a specific rate for individuals who continued to smoke cigarettes. Overall, switching to vapes was associated with a seven percent increased risk of serious eye disease relative to quitting nicotine completely.

The researchers attribute this risk primarily to nicotine itself. Even in the absence of tar and other toxins found in burning tobacco, nicotine constricts blood vessels, reduces oxygen flow to sensitive tissues, and fuels chronic inflammation. Over time, these physiological changes take a toll on the eyes, leading to conditions such as diabetic retinopathy, cataracts, glaucoma, and age-related macular degeneration. Diabetic retinopathy, which damages the blood vessels in the retina, is particularly dangerous as it can lead to blindness.

The impact of this risk was not uniform across all eye conditions. While the overall risk increased by seven percent for switchers, the most significant disparity appeared in diabetic retinopathy. Those who switched to vaping faced a 24 percent higher risk of developing this specific condition compared to individuals who eliminated all nicotine from their lives. This data underscores the importance of complete cessation over substitution when considering public health and regulatory guidance regarding nicotine products.

A significant gap in eye health appeared roughly one year after individuals stopped using traditional cigarettes, and this disparity grew slightly over time. This trend suggests that continuing to use vaping products after quitting smoking may still damage vision.

The study results remained consistent regardless of income levels, physical activity, body weight, or pre-existing health conditions. These findings indicate that the negative impact of vaping on eyesight applies broadly across diverse populations.

However, researchers caution that the study group was nearly 98 percent male, which limits how well these results apply to women. They also noted that the average follow-up period of 4.6 years might be too short to detect slower-developing conditions like cataracts or macular degeneration.

Published in the American Journal of Ophthalmology, the study highlights two primary conclusions regarding these health risks. First, the heightened risk for diabetic retinopathy likely stems from nicotine damaging tiny blood vessels within the eye.

Second, the connection to refractive disorders may result from nicotine affecting the eye's surface and its ability to focus light correctly. Earlier investigations have already linked both smoking and vaping to these specific focusing issues.

Although the overall increase in risk appears modest, the conditions remain highly prevalent among the American population. Approximately 9.6 million Americans suffer from diabetic retinopathy, which affects about 26 percent of all people living with diabetes.

More than 150 million Americans experience refractive disorders, while roughly 20 million live with some form of age-related macular degeneration. Additionally, about 4.2 million Americans have glaucoma, and between 25 and 30 million have cataracts.

Experts emphasize that even a small rise in risk can impact millions of people across the nation. Consequently, doctors should advise patients about the eye risks associated with switching to vapes instead of quitting nicotine entirely.